FDA on breakthrough therapy requests by therapy area 2019

This statistic displays the share of breakthrough therapy requests to the FDA by therapeutic area, in the United States, as of 2019. As of end-September of that year, 26 percent of requests for breakthrough therapies came from the oncology area. The FDA recommends that submissions for breakthrough therapy designations should be made prior to phase III.

Distribution of FDA breakthrough therapy requests by therapy area in 2019

Percentage of breakthrough therapy requests
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

December 2019

Region

Worldwide, United States

Survey time period

as of September 30, 2019

Supplementary notes

FDA: Food and Drug Administration.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Oncology"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.